SIMILAC ISOMIL

Similac® Isomil® (for newborns and up) 900g

A CLINICALLY PROVEN SOLUTION FOR DIFFERENT FEEDING ISSUES

  • Suitable for infants (newborns and up) with IgE-mediated cow milk protein allergy1 and lactose intolerance-associated diarrhea2
  • Clinically proven soy formula to support developing immune system3 and normal growth4
  • Adequate nutrition with high quality soy, lactose free and palm olein free formula

 

IMPORTED FROM THE NETHERLANDS

Ingredients

Hydrolyzed corn starch, soy protein isolate, high oleic sunflower oil, sucrose, coconut oil, soy oil, MINERALS (calcium phosphate tribasic, potassium citrate, sodium chloride, potassium chloride, magnesium chloride, ferrous sulfate, zinc sulfate, cupric sulfate, potassium iodide, sodium selenite), fructo-oligosaccharides, emulsifier (soy lecithin), arachidonic acid (AA), VITAMINS (ascorbic acid, choline chloride, antioxidant (ascorbyl palmitate), antioxidant (mixed tocopherols), niacinamide, calcium pantothenate, d-alpha tocopheryl acetate, Vitamin A palmitate, riboflavin, thiamine hydrochloride, pyridoxine hydrochloride, folic acid, phylloquinone, biotin, Vitamin D3, cyanocobalamin), I-methionine, docosahexaenoic acid (DHA), m-inositol, taurine, I-tryptophan, I-carnitine tartrate, CAROTENOIDS (lutein, beta carotene).

Contains soy ingredient. Source of protein - soy protein.

Nutrition Information

Nutrition Information
UnitPer 100gPer 100ml
 
UnitPer 100gPer 100ml
Energykcal51168Folic acidµg608.0
Proteing12.801.71Thiamine (Vitamin B1)mg0.440.06
Total Fatg27.43.67Riboflavin (Vitamin B2)mg0.420.06
  Saturated fatty acidsg9.71.3Vitamin B6mg0.240.03
  Trans fatty acidsmg709.4Vitamin B12µg1.040.14
  α-Linolenic acidmg38051Niacinmg3.80.51
  Linoleic acidg4.80.64Pantothenic acidmg3.00.40
  Arachidonic acid (AA)mg10013Biotinµg152.0
     Docosahexaenoic acid (DHA)mg506.7Sodiummg24333
Total Carbohydratesg54.07.22Potassiummg46262
  Fiber (FOS)g1.600.21Chloridemg35948
     Sugarsg162.1Calciummg42557
Taurinemg273.6Phosphorusmg30441
Carnitinemg7.20.96Magnesiummg324.3
Inositolmg729.6Ironmg6.20.83
Cholinemg547.2Zincmg4.80.64
Vitamin A (Palmitate)µg RE57076Manganesemg0.240.03
Vitamin D3µg8.01.1Copperµg28538
Vitamin Emg α-TE7.521.0Iodineµg608.0
Vitamin Kµg334.4Seleniumµg9.61.3
Vitamin Cmg516.8    

RELATED PRODUCTS

RELATED CONTENT

Examining guidelines and new evidence in oncology nutrition

Examining guidelines and new evidence in oncology nutrition

Main Image


resource

Tagname
Article
title
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. 

Publish Date:
Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Main Image

resource

Tagname
ARTICLE
title
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.

Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Main Image

resource

Tagname
Article
title
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract

This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.

Publish Date:
Jan 2019

References:

  1. Zeiger RS, et al. J Pediatr. 1999;134(5):614-622. 
  2. Santosham M, et al. Pediatrics. 1991;87(5):619-622. 
  3. Ostrom KM, et al. J Pediatr Gastroenterol Nutr. 2002;34(2):137-144. 
  4. Lasekan JB, et al. Clin Pediatr (Phila). 1999;38(10):563-571

 

HKG.2025.58161.PND

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.